(Q79613390)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18923384%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

title

An in vitro model of light chain deposition disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18923384%20AND%20SRC:MED&resulttype=core&format=json

Light chain deposition disease

24 December 2019

main subject

1 reference

John Keeling

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18923384%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Guillermo A Herrera

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18923384%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

language of work or name

English

0 references

publication date

15 October 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18923384%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18923384%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18923384%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18923384%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

634-645

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18923384%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.2008.504

24 December 2019

exact match

0 references

cites work

Manifestations of systemic light chain deposition

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Renal manifestations of plasma cell dyscrasias: an appraisal from the patients' bedside to the research laboratory

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Apoptosis in glomerular sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Growth factors in monoclonal light-chain--related renal diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Functional structure and composition of the extracellular matrix

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Meet the tenascins: multifunctional and mysterious

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Tenascin-C hexabrachion assembly is a sequential two-step process initiated by coiled-coil alpha-helices

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.2008.504

1 reference

7 January 2021

Tenascins: regulation and putative functions during pathological stress

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Evidence for combinatorial variability of tenascin-C isoforms and developmental regulation in the mouse central nervous system.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Extracellular matrix components in breast carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Increased expression of tenascin C by keloids in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Tenascin is an important component of the glomerular extracellular matrix in normal and pathologic conditions

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

In vitro modulation of AL-amyloid formation by human mesangial cells exposed to amyloidogenic light chains

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

New functions for the matrix metalloproteinases in cancer progression

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Evaluation of some newer matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Matrix metalloproteinases: effectors of development and normal physiology

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Matrix metalloproteinases in repair

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

MMP-1: the elder of the family

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Regulation of matrix biology by matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Matrix metalloproteinases and mesangial remodeling in light chain-related glomerular damage

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Pericellular activation of proMMP-7 (promatrilysin-1) through interaction with CD151.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Quick guide. Matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Susceptibility of tenascin to degradation by matrix metalloproteinases and serine proteinases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Localization of matrix metalloproteinases and their inhibitors in experimental progressive kidney scarring

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

The structure and function of tenascins in the nervous system

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Cytotactin binding: inhibition of stimulated proliferation and intracellular alkalinization in fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Advanced glycation end products decrease mesangial cell MMP-7: a role in matrix accumulation in diabetic nephropathy?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Disappearance of nodular mesangial lesions in a patient with light chain nephropathy after long-term chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Resolution of nodular glomerular lesions in a patient with light-chain nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Improved methods for culturing rat glomerular cells.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021

Antigen retrieval immunohistochemistry: past, present, and future

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.504

7 January 2021